Abiraterone acetate
Tracked across 1 events · 6 articles · First seen Mar 09, 2026 · Last active Mar 09, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Abiraterone acetate, a drug developed by Cancer Research UK scientists, is highlighted as an improved treatment contributing to the decline in prostate cancer mortality.
Mar 09, 2026 · 6 articles
ERGEN INTELLIGENCE
Track Abiraterone acetate live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard